AARON THRIFT to Gastroesophageal Reflux
This is a "connection" page, showing publications AARON THRIFT has written about Gastroesophageal Reflux.
Connection Strength
4.375
-
Helicobacter pylori Infection and Gastroesophageal Reflux Disease-Barrett's Esophagus-Esophageal Adenocarcinoma Sequence: Reply From Authors. Am J Gastroenterol. 2018 11; 113(11):1724-1725.
Score: 0.536
-
Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Am J Gastroenterol. 2018 08; 113(8):1148-1155.
Score: 0.523
-
Risk Profiles for Barrett's Esophagus Differ between New and Prevalent, and Long- and Short-Segment Cases. PLoS One. 2016; 11(12):e0169250.
Score: 0.473
-
Determination of risk for Barrett's esophagus and esophageal adenocarcinoma. Curr Opin Gastroenterol. 2016 07; 32(4):319-24.
Score: 0.457
-
Unravelling the Riddle of Gastroesophageal Reflux Disease, Obesity, and Barrett's Esophagus. Clin Gastroenterol Hepatol. 2015 Dec; 13(13):2273-5.
Score: 0.431
-
A multibiomarker risk score helps predict risk for Barrett's esophagus. Clin Gastroenterol Hepatol. 2014 Aug; 12(8):1267-71.
Score: 0.384
-
Age at onset of GERD symptoms predicts risk of Barrett's esophagus. Am J Gastroenterol. 2013 Jun; 108(6):915-22.
Score: 0.366
-
Multitrait genetic association analysis identifies 50 new risk loci for gastro-oesophageal reflux, seven new loci for Barrett's oesophagus and provides insights into clinical heterogeneity in reflux diagnosis. Gut. 2022 06; 71(6):1053-1061.
Score: 0.162
-
Prevalence of Barrett's esophagus and performance of societal?screening guidelines in an unreferred primary care population of U.S. veterans. Gastrointest Endosc. 2021 02; 93(2):409-419.e1.
Score: 0.151
-
Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus. Am J Gastroenterol. 2016 11; 111(11):1528-1535.
Score: 0.116
-
Weight Change and Weight Cycling Are?Not?Associated With Risk of Barrett's?Esophagus. Clin Gastroenterol Hepatol. 2016 12; 14(12):1839-1840.
Score: 0.114
-
The epidemic of oesophageal carcinoma: Where are we now? Cancer Epidemiol. 2016 Apr; 41:88-95.
Score: 0.111
-
Symptoms of Obstructive Sleep Apnea, Gastroesophageal Reflux and the Risk of Barrett's Esophagus in a Population-Based Case-Control Study. PLoS One. 2015; 10(6):e0129836.
Score: 0.106
-
Risk factors and populations at risk: selection of patients for screening for Barrett's oesophagus. Best Pract Res Clin Gastroenterol. 2015 Feb; 29(1):41-50.
Score: 0.103
-
Risk factors for Barrett's esophagus compared between African Americans and non-Hispanic Whites. Am J Gastroenterol. 2014 Dec; 109(12):1870-80.
Score: 0.102
-
A clinical risk prediction model for Barrett esophagus. Cancer Prev Res (Phila). 2012 Sep; 5(9):1115-23.
Score: 0.087
-
Helicobacter pylori infection and the risks of Barrett's oesophagus: a population-based case-control study. Int J Cancer. 2012 May 15; 130(10):2407-16.
Score: 0.082
-
Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterology. 2020 12; 159(6):2065-2076.e1.
Score: 0.038
-
Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma. Dig Dis Sci. 2019 02; 64(2):367-372.
Score: 0.034